Clarence J. Maring - Palatine IL Yu Gui Gu - Grayslake IL Hui-Ju Chen - Grayslake IL Yuanwei Chen - North Haven CT David A. Degoey - Kenosha WI William J. Flosi - Des Plaines IL Vincent L. Giranda - Gurnee IL David J. Grampovnik - Waukegan IL Warren M. Kati - Gurnee IL Dale J. Kempf - Libertyville IL April Kennedy - Grayslake IL Larry L. Klein - Lake Forest IL Allan C. Krueger - Gurnee IL Zhen Lin - Gurnee IL Darold L. Madigan - Elk Grove Village IL Keith F. McDaniel - Grayslake IL Steven W. Muchmore - Libertyville IL Hing L. Sham - Mundelein IL Kent D. Stewart - Gurnee IL Vincent S. Stoll - Libertyville IL Minghua Sun - Libertyville IL Noah P. Tu - Gurnee IL Frank L. Wagenaar - Gurnee IL Gary T. Wang - Niles IL Sheldon Wang - Grayslake IL Paul E. Wiedeman - Deerfield IL Yibo Xu - Ridgefield CT Ming C. Yeung - Grayslake IL Chen Zhao - Libertyville IL Stephen Hanessian - Beaconsfield, CA Malken Bayrakdarian - Verdun, CA Xuehong Luo - Montreal, CA
Disclosed are compounds of the formula: which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Five-Membered Carbocyclic And Heterocyclic Inhibitors Of Neuraminidases
Clarence J. Maring - Palatine IL Yuanwei Chen - North Haven CT David A. Degoey - Kenosha WI Vincent L. Giranda - Gurnee IL David J. Grampovnik - Waukegan IL Yu Gui Gu - Grayslake IL Warren M. Kati - Gurnee IL Dale J. Kempf - Libertyville IL April Kennedy - Grayslake CO Allan C. Krueger - Gurnee IL Zhen Lin - Gurnee IL Darold L. Madigan - Elk Grove Village IL Steven W. Muchmore - Libertyville IL Hing L. Sham - Mundelein IL Kent D. Stewart - Gurnee IL Vincent S. Stoll - Libertyville IL Minghua Sun - Libertyville IL Gary T. Wang - Niles IL Sheldon Wang - Grayslake IL Ming C. Yeung - Grayslake IL Chen Zhao - Libertyville IL
Disclosed are compounds of the formula: which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Clarence J. Maring - Palatine IL Yu Gui Gu - Grayslake IL Hui-Ju Chen - Grayslake IL Yuanwei Chen - North Haven CT David A. Degoey - Kenosha WI William J. Flosi - Des Plaines IL Vincent L. Giranda - Gurnee IL David J. Grampovnik - Waukegan IL Warren M. Kati - Gurnee IL Dale J. Kempf - Libertyville IL April Kennedy - Boulder CO Larry L. Klein - Lake Forest IL Allan C. Krueger - Gurnee IL Zhen Lin - Gurnee IL Darold L. Madigan - Elk Grove Village IL Keith F. McDaniel - Wauconda IL Steven W. Muchmore - Libertyville IL Hing L. Sham - Mundelein IL Kent D. Stewart - Gurnee IL Vincent S. Stoll - Libertyville IL Minghua Sun - Libertyville IL Noah P. Tu - Gurnee IL Frank L. Wagenaar - Gurnee IL Gary T. Wang - Niles IL Sheldon Wang - Grayslake IL Paul E. Wiedeman - Deerfield IL Yibo Xu - New Milford CT Ming C. Yeung - Grayslake IL Chen Zhao - Libertyville IL Stephen Hanessian - Beaconsfield, CA Malken Bayrakdarian - Verdun, CA Xuehong Luo - Montreal, CA
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A61K 3140
US Classification:
514423
Abstract:
Disclosed are compounds of the formula: which are useful for inhibiting neuraminidases from disease-causing microorganisms, especially, influenza neuraminidase. Also disclosed are compositions and methods for preventing and treating diseases caused by microorganisms having a neuraminidase, processes for preparing the compounds and synthetic intermediates used in these processes.
Cardiolipin Compositions Their Methods Of Preparation And Use
The invention provides new synthetic routes for cardiolipin with different fatty acids and/or alkyl chains with varying chain length and also with or without unsaturation. The reaction schemes can be used to generate new forms of cardiolipin, including cardiolipin variants. The cardiolipin prepared by the present methods can conveniently be incorporated into liposomes and other lipid formulations that can also include active agents such as hydrophobic or hydrophilic drugs. Such formulations can be used to treat diseases or in diagnostic and/or analytical assays. Liposomes also can include ligands, e.g., for targeting them to a cell type or specific tissue.
Direct Detection Of Single Molecules On Microparticles
- Abbott Park IL, US Patrick J. Macdonald - Abbott Park IL, US Kerry M. Swift - Abbott Park US, US Sergey Y. Tetin - Abbott Park IL, US Brenda Calfin - Abbott Park IL, US Zhen Lin - Abbott Park IL, US Richard Haack - Abbott Park IL, US Mark R. Pope - Abbott Park IL, US John Prostko - Abbott Park IL, US Xiaoxing Qiu - Abbott Park IL, US Felicia Bogdan - Abbott Park IL, US
International Classification:
G01N 33/58 G01N 15/14 G01N 33/543
Abstract:
The disclosure provides methods of analyzing an analyte of interest in a biological sample using fluorescent agents and macroconjugates which comprise a core containing a cross-linked polymer or protein, tags, specific binding members or fragments thereof, and optionally carrier proteins. Also provided are methods of analyzing two or more analytes of interest in a biological sample in a single assay using microparticles and detection conjugates comprising different fluorophore labels, acquiring transmitted light and fluorescent images of the microparticles, and using a customized image analysis process to analyze the acquired images.